Search

Search Constraints

You searched for: Author/Creator Shinozaki, Eiji

Search Results

1. A modified MethyLight assay predicts the clinical outcomes of anti‐epidermal growth factor receptor treatment in metastatic colorectal cancer. Issue 3 (28th January 2022)

2. Association Between Regorafenib Dose and Efficacy Against Metastatic Colorectal Cancer in a Real-World Setting. Issue 4 (4th October 2021)

3. Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer. (21st December 2018)

5. Correlation between circulating tumor DNA and carcinoembryonic antigen levels in patients with metastatic colorectal cancer. (24th November 2021)

6. Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy?. Issue 1 (December 2015)

7. Early hypertension and neutropenia are predictors of treatment efficacy in metastatic colorectal cancer patients administered FOLFIRI and vascular endothelial growth factor inhibitors as second‐line chemotherapy. (21st December 2020)

8. Effects of Metastatic Sites on Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer. (11th May 2022)

10. Implementation of microsatellite instability testing for the assessment of solid tumors in clinical practice. (26th December 2022)